Latest News about AMGN
Recent news which mentions AMGN
Billionaires Loaded Up on These 3 Stocks in the Fourth Quarter of 2022
February 15, 2023
From Motley Fool
Amgen plans mega bond deal to help fund $28 billion Horizon Therapeutics acquisition
February 14, 2023
From MarketWatch
From InvestorPlace
$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
February 13, 2023
Tickers
AMGN
From Benzinga
Top 5 Health Care Stocks That Could Blast Off This Month
February 13, 2023
From Benzinga
Beat the Dow Jones With This Unstoppable Dividend Stock
February 08, 2023
From Motley Fool
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?
February 04, 2023
Tickers
AMGN
From Motley Fool
Top 5 Health Care Stocks That May Rally
February 03, 2023
From Benzinga
The 7 Most Undervalued Dow Stocks to Buy in February 2023
February 02, 2023
From InvestorPlace
Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline
February 01, 2023
From Benzinga
From MarketWatch
These 20 stocks led the January rally
January 31, 2023
From MarketWatch
This newsletter editor has been recommending stocks and bonds this year and says the rally has room to run
January 31, 2023
From MarketWatch
Nasdaq, S&P Futures Lower As Powell & Team Kick Off 2-Day Fed Meeting: Analyst Says Positive January Harbinger Of Good Times
January 31, 2023
From Benzinga
Earnings Scheduled For January 31, 2023
January 31, 2023
From Benzinga
Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts
January 30, 2023
From InvestorPlace
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
From Benzinga
2 Top Biotech Stocks to Buy for the Long Haul
January 26, 2023
From Motley Fool
Dogs of the Dow 2023: 5 Dividend Stocks for Income Investors
January 24, 2023
From InvestorPlace
2 Top Passive-Income Stocks to Own in 2023
January 22, 2023
From Motley Fool
3 Dividend Stocks You Can Safely Hold for Years
January 21, 2023
From Motley Fool
Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide
January 19, 2023
From Benzinga
Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023
From MarketWatch
From Benzinga
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
January 10, 2023
Tickers
AMGN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.